ANAHEIM, Calif. — Nearly 38 percent of lesbians polled in a national survey were not routinely screened for cervical cancer, putting them at risk of developing a highly preventable cancer, according to a University of Maryland School of Medicine study being presented at the 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research. Cervical cancer is caused by a sexually transmitted virus, the human papillomavirus (HPV), and can be detected through regular Pap smears.
The percentage of lesbians not being screened as recommended is higher than for women overall. According to information compiled by the Centers for Disease Control’s Risk Factor Surveillance System (BRFSS), 13 percent of women have not had a Pap test in the last three years.
“This study highlights an often-overlooked cancer disparity,” says the study’s author, J. Kathleen Tracy, Ph.D., an associate professor of epidemiology and public health at the University of Maryland School of Medicine and a researcher at the University of Maryland Marlene and Stewart Greenebaum Cancer Center. “We know that HPV can be transmitted during same-sex sexual activity, so lesbians are at risk of developing cervical cancer. If these women aren’t screened, they are at increased risk of getting this type of cancer by missing opportunities to identify precursor cervical abnormalities that can be treated.”
Dr. Tracy, a health psychologist, is presenting these results at the cancer prevention conference, which is sponsored by the American Association for Cancer Research (AACR).
According to Dr. Tracy, a key barrier to effective screening among lesbians is a lack of communication with their health care providers. “We shouldn’t underestimate the importance of open communication between patient and provider,” Dr. Tracy says. “Our research showed that women who were open with their primary care doctors and gynecologists about their sexual orientation were nearly 2½ to three times more likely to have routine screening than those who did not disclose it. They also were more likely to be screened if their doctors recommended it and they believed that having routine Pap tests was beneficial.”
E. Albert Reece, M.D., Ph.D., M.B.A., vice president for medical affairs at the University of Maryland and the John Z. and Akiko K. Bowers Distinguished Professor and dean of the University of Maryland School of Medicine, says, “Cervical cancer is very treatable if detected early through routine screening with Pap tests. Dr. Tracy’s research shows that a significant percentage of the lesbian population is not being screened as recommended. We need to eliminate barriers to screening for this subset of women and to educate them on the benefits.”
Dr. Tracy and her colleagues sent a standardized internet survey in 2010 and early 2011 to 3,000 women who identified themselves as lesbians. Of these, 1,006 women responded to the survey, with nearly 38 percent reporting that they were not getting regular cervical cancer screening. Sixty-two percent said they were routinely screened.
The two most common reasons for not getting Pap tests as recommended: not having a physician referral (17.5 percent) and not having a physician (17.3 percent). “Physician recommendation appeared to be a potent determinant of regular screening behavior,” Dr. Tracy says. “Routine screeners perceived more benefits and fewer barriers to screening, and knew that not having a Pap test put them at increased risk for cervical cancer, than did women who were not screened.”
“Women who identify as lesbian are at potentially elevated risk of cervical cancer because they are not routinely screened,” researchers concluded. “Evidence-based interventions should be developed that address critical health beliefs that undermine participation in screening. Given the value placed on physician recommendation, patient-provider communication may serve as the optimal mode for intervention delivery.”
Women should begin to have Pap tests at the age of 21 or within three years of becoming sexually active, whichever comes first. For many years, women were told to have yearly Pap tests until age 30 and then have them every two to three years if they had three normal tests in a row. The American Cancer Society now recommends that women age 21 to 29 have the test every three years. Women age 30 to 65 should have a Pap test and an HPV test every five years. A doctor may suggest more frequent screening if a woman has risk factors for cervical cancer.
The study was funded by the National Cancer Institute. (R21CA120635).
About the University of Maryland School of Medicine
Established in 1807, the University of Maryland School of Medicine is the first public medical school in the United States, and the first to institute a residency-training program. The School of Medicine was the founding school of the University of Maryland and today is an integral part of the 11-campus University System of Maryland. On the University of Maryland’s Baltimore campus, the School of Medicine serves as the anchor for a large academic health center which aims to provide the best medical education, conduct the most innovative biomedical research and provide the best patient care and community service to Maryland and beyond. www.medschool.umaryland.edu.
About the University of Maryland Marlene and Stewart Greenebaum Cancer Center
The University of Maryland Marlene and Stewart Greenebaum Cancer Center is a National Cancer Institute-designated cancer center, which is part of the University of Maryland Medical Center and the University of Maryland School of Medicine. The center is recognized for its active clinical and basic science research program. It has comprehensive programs to treat all types of cancer and is a major referral center for patients throughout Maryland and the region. It is ranked 11th among 900 cancer centers nationwide by U.S. News and World Report. For more information about the center, go to www.umgcc.org.